Table 2.
Statistical analysis of the genetic variants most commonly related to hypertriglyceridaemia in both the SLE and control groups
| Gene | Control group (n=73) | SLE group (n=73) | P value |
| ZPR1 (c.*724C>G) | |||
| CC | 50 (68.5) | 51 (69.9) | |
| CG | 23 (31.5) | 21 (28.8) | NA |
| GG | 0 (0) | 1 (1.4) | |
| Grouped: | |||
| CG or GG | 23 (31.5) | 22 (30.1) | 0.858 |
| APOA5 (c.56C>G) | |||
| CC | 66 (90.4) | 60 (82.2) | |
| CG | 7 (9.6) | 12 (16.4) | NA |
| GG | 0 (0.0) | 1 (1.4) | |
| Grouped | |||
| CG or GG | 7 (9.6) | 13 (17.8) | 0.149 |
| GCKR (c.1337C>T) | |||
| CC | 20 (27.4) | 28 (38.4) | |
| CT | 37 (50.7) | 33 (45.2) | 0.344 |
| TT | 16 (21.9) | 12 (16.4) | |
| APOE E2/E3-4 | 8 (11.1) | 4 (5.5) | 0.218 |
| APOE E4/E2-3 | 13 (18.1) | 13 (17.8 %) | 0.969 |
Data are expressed as n (%).
NA, not statistically applicable.